SCHEMBL9934244

SCHEMBL9934244

C[C@H](CO)N1Cc2c(N)ccc(Cl)c2C1=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.35
PIK3CG P48736 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7950747 0.84 ADORA2A (0.39) ADORA2APIK3CG
SCHEMBL9933420 0.78 MEN1 (0.32)
SCHEMBL9934296 0.75 BRD4 (0.40)
SCHEMBL9973906 0.73 ADORA2A (0.36) ADORA2A
SCHEMBL14444112 0.68 L3MBTL1 (0.38)
SCHEMBL9935659 0.68 PARP1 (0.46)
Hydrochloric Acid SCHEMBL7950506 0.66 IDH1 (0.33)
SCHEMBL14444097 0.62 IDH1 (0.30)
SCHEMBL18882839 0.61 ADORA2A (0.39) ADORA2A
SCHEMBL9935445 0.60 S100A4 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157494-A1 ISOINDOLYL COMPOUNDS HARRIS III RALPH NEW (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157494-A1 ISOINDOLYL COMPOUNDS P2RX7, P2RX3, P2RX1 ADORA2A 18/4885PIK3CG 1523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.